Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - Vyant Bio, Inc. | Financial_Report.xls |
| EX-32.1 - EXHIBIT 32.1 - Vyant Bio, Inc. | a201410-kex321.htm |
| EX-31.1 - EXHIBIT 31.1 - Vyant Bio, Inc. | a201410-kex311.htm |
| EX-31.2 - EXHIBIT 31.2 - Vyant Bio, Inc. | a201410-kex312.htm |
| EX-32.2 - EXHIBIT 32.2 - Vyant Bio, Inc. | a201410-kex322.htm |
| EX-21.1 - EXHIBIT 21.1 - Vyant Bio, Inc. | a201410-kex211.htm |
| 10-K - 10-K - Vyant Bio, Inc. | cgix-20141231x10xk.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in Registration Statement Nos. 333-191520, 333-191521 and 333-196198 on Form S-8 and in Registration Statement No.333-196374 on Form S-3 of Cancer Genetics, Inc. and subsidiaries of our report dated March 16, 2015, relating to our audits of the consolidated financial statements appearing in the Annual Report on Form 10-K of Cancer Genetics, Inc. and subsidiaries for the year ended December 31, 2014.
/s/ McGladrey LLP
Des Moines, Iowa
March 16, 2015